Legal Opinion

In re Epipen (Epinephrine Injection, USP) Employee Retirement Income Security Act (Erisa) Litigation

United States Judicial Panel on Multidistrict Litigation

Decided December 5, 2017No. MDL No. 2802Published

1Opinion of the Court

ORDER DENYING TRANSFER

SARAH S. VANCE, Chair

Before the Panel:* Plaintiffs in the Klein action listed on Schedule A move under 28 U.S.C. § 1407 to centralize pretrial proceedings in this litigation in the District of Minnesota. This litigation consists of two actions—the Brannon action pending in the District of Kansas and the Klein action pending in the District of Minnesota—as listed on Schedule A.1 All responding parties oppose centralization. These include: (1) all defendants in the Brannon and Klein actions;2 (2) the Bran-non plaintiffs; and (3) MDL No. 2785 defendants Mylan Inc., Mylan…

2Cases cited5 opinions

  1. In Re Eli Lilly & Co.(cephalexin Monohydrate)United States Judicial Panel on Multidistrict Litigation · 1978
  2. In re Best Buy Co.United States Judicial Panel on Multidistrict Litigation · 2011
  3. In re Gerber Probiotic Products Marketing & Sales Practices LitigationUnited States Judicial Panel on Multidistrict Litigation · 2012
  4. In re EpiPen Marketing, Sales Practices & Antitrust LitigationUnited States Judicial Panel on Multidistrict Litigation · 2017
  5. In re Truvia Natural Sweetener Marketing & Sales Practices LitigationUnited States Judicial Panel on Multidistrict Litigation · 2014

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API